As cell therapies scale, developers face a choice: redesign processes for all-in-one systems or manage complex bespoke ...
What keeps Joseph Makowiecki excited is the recurrent need for multilayered connectivity in bioprocess development and manufacturing, particularly when it comes to new therapeutic modalities, flexible ...